IL104484A - Amidodicarbonimedicides (N, N Converted diamides are derived from hydroxylams and their pharmaceutical compositions - Google Patents

Amidodicarbonimedicides (N, N Converted diamides are derived from hydroxylams and their pharmaceutical compositions

Info

Publication number
IL104484A
IL104484A IL10448493A IL10448493A IL104484A IL 104484 A IL104484 A IL 104484A IL 10448493 A IL10448493 A IL 10448493A IL 10448493 A IL10448493 A IL 10448493A IL 104484 A IL104484 A IL 104484A
Authority
IL
Israel
Prior art keywords
group
mono
compound
carbon atoms
substituted
Prior art date
Application number
IL10448493A
Other languages
English (en)
Hebrew (he)
Other versions
IL104484A0 (en
Original Assignee
Jacobus Pharmaceutical Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jacobus Pharmaceutical Company filed Critical Jacobus Pharmaceutical Company
Publication of IL104484A0 publication Critical patent/IL104484A0/xx
Publication of IL104484A publication Critical patent/IL104484A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/24—Y being a hetero atom
    • C07C279/26—X and Y being nitrogen atoms, i.e. biguanides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/10—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C323/11—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/13—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and singly-bound oxygen atoms bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Detergent Compositions (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Seasonings (AREA)
  • Luminescent Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
IL10448493A 1992-02-14 1993-01-22 Amidodicarbonimedicides (N, N Converted diamides are derived from hydroxylams and their pharmaceutical compositions IL104484A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/837,258 US5322858A (en) 1992-02-14 1992-02-14 N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines

Publications (2)

Publication Number Publication Date
IL104484A0 IL104484A0 (en) 1993-05-13
IL104484A true IL104484A (en) 1998-07-15

Family

ID=25273975

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10448493A IL104484A (en) 1992-02-14 1993-01-22 Amidodicarbonimedicides (N, N Converted diamides are derived from hydroxylams and their pharmaceutical compositions

Country Status (25)

Country Link
US (1) US5322858A (cs)
EP (1) EP0625967B1 (cs)
JP (1) JP3207200B2 (cs)
KR (1) KR950700243A (cs)
CN (1) CN1057520C (cs)
AT (1) ATE157352T1 (cs)
AU (1) AU668709B2 (cs)
CA (1) CA2129430C (cs)
CZ (1) CZ294257B6 (cs)
DE (1) DE69313438T2 (cs)
DK (1) DK0625967T3 (cs)
EG (1) EG20476A (cs)
ES (1) ES2108862T3 (cs)
FI (1) FI943738A (cs)
GR (1) GR3025429T3 (cs)
HU (1) HU220389B (cs)
IL (1) IL104484A (cs)
MX (1) MX9300688A (cs)
NO (1) NO302616B1 (cs)
NZ (1) NZ245865A (cs)
OA (1) OA10094A (cs)
PL (2) PL173258B1 (cs)
RU (1) RU2133737C1 (cs)
WO (1) WO1993016037A1 (cs)
ZA (1) ZA93974B (cs)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4321444A1 (de) * 1993-06-28 1995-01-05 Bernd Prof Dr Clement Pharmazeutische Zubereitung
US6551614B2 (en) * 2001-03-14 2003-04-22 Jacobus Pharmaceutical Co., Inc. Antimalarial N,N′-substituted biguanides derived from hydroxylamines
CA2477604A1 (en) 2002-03-13 2003-09-25 Signum Biosciences, Inc. Modulation of protein methylation and phosphoprotein phosphate
US7256218B2 (en) * 2002-11-22 2007-08-14 Jacobus Pharmaceutical Company, Inc. Biguanide and dihydrotriazine derivatives
CN1738794B (zh) * 2002-11-22 2010-12-22 雅各布斯制药公司 双胍和二氢三嗪衍生物
EP1843734A4 (en) * 2005-02-03 2008-09-10 Signum Biosciences Inc COMPOSITIONS AND METHOD FOR INTENSIFYING COGNITIVE FUNCTIONS
US7923041B2 (en) 2005-02-03 2011-04-12 Signum Biosciences, Inc. Compositions and methods for enhancing cognitive function
KR101578949B1 (ko) 2007-10-08 2015-12-18 엠엠브이 메디슨즈 포 말라리아 벤처 가요성 측쇄를 가지는 항말라리아 화합물
BRPI0817892A2 (pt) * 2007-10-13 2015-05-05 Univ Cornell Composição, métodos para estimular uma resposta imune para mycobacterium avium
CN102014897B (zh) 2008-04-21 2015-08-05 西格纳姆生物科学公司 化合物、组合物和其制备方法
CN102088956A (zh) * 2008-05-09 2011-06-08 托马有限公司 氯胍用于治疗皮肤/粘膜疾病
US10829440B2 (en) 2015-06-12 2020-11-10 Brown University Antibacterial compounds and methods of making and using same
WO2018106907A1 (en) 2016-12-08 2018-06-14 Novatarg, Inc. Fused bicyclic alkylene linked imidodicarbonimidic diamides, methods for synthesis, and uses in therary
US11555010B2 (en) 2019-07-25 2023-01-17 Brown University Diamide antimicrobial agents

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB603070A (en) * 1946-01-25 1948-06-08 Albert Frederick Crowther Manufacture of biguanide derivatives
GB665680A (en) * 1948-02-20 1952-01-30 Rhone Poulenc Sa Improvements in or relating to the production of n-p-chlorophenyl-n-isopropyl biguanide
DE824942C (de) * 1949-01-31 1951-12-17 Ici Ltd Verfahren zur Herstellung von Biguanidderivaten
GB667116A (en) * 1949-04-25 1952-02-27 Albert Frederick Crowther Manufacture of biguanide derivatives
GB814563A (en) * 1956-11-15 1959-06-10 Vitamins Ltd Biguanides
GB1270831A (en) * 1968-11-22 1972-04-19 Beecham Group Ltd Di-hydro triazine derivatives and processes for their manufacture
GB1250531A (cs) * 1969-01-01 1971-10-20
US3723429A (en) * 1969-11-06 1973-03-27 Beecham Group Ltd Di-hydro triazine derivatives
US3660394A (en) * 1970-01-23 1972-05-02 Vitamins Ltd 4 6-dibenzo-1 2-dihydro-aryloxy-1 3 5-triazines

Also Published As

Publication number Publication date
HUT68802A (en) 1995-07-28
IL104484A0 (en) 1993-05-13
RU2133737C1 (ru) 1999-07-27
ZA93974B (en) 1993-09-14
CA2129430C (en) 2004-04-06
CZ196494A3 (en) 1995-10-18
PL173258B1 (pl) 1998-02-27
ES2108862T3 (es) 1998-01-01
OA10094A (en) 1996-12-18
JPH07503730A (ja) 1995-04-20
HU9401976D0 (en) 1994-09-28
JP3207200B2 (ja) 2001-09-10
DE69313438D1 (de) 1997-10-02
CN1076689A (zh) 1993-09-29
PL172001B1 (pl) 1997-07-31
NO942988L (no) 1994-10-05
GR3025429T3 (en) 1998-02-27
MX9300688A (es) 1993-08-01
FI943738A (fi) 1994-10-12
EG20476A (en) 1999-05-31
EP0625967A1 (en) 1994-11-30
NZ245865A (en) 1996-02-27
CA2129430A1 (en) 1993-08-15
HU220389B (hu) 2002-01-28
RU94039539A (ru) 1997-05-27
US5322858A (en) 1994-06-21
CN1057520C (zh) 2000-10-18
DE69313438T2 (de) 1998-03-19
FI943738A0 (fi) 1994-08-12
NO302616B1 (no) 1998-03-30
WO1993016037A1 (en) 1993-08-19
ATE157352T1 (de) 1997-09-15
DK0625967T3 (da) 1998-03-23
CZ294257B6 (cs) 2004-11-10
KR950700243A (ko) 1995-01-16
EP0625967B1 (en) 1997-08-27
AU668709B2 (en) 1996-05-16
AU3475993A (en) 1993-09-03
NO942988D0 (no) 1994-08-12

Similar Documents

Publication Publication Date Title
US5322858A (en) N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
KR920021523A (ko) 신규한 우레아 유도체, 이의 제조 방법 및 이들을 함유하는 약제학적 조성물
US6147063A (en) Therapeutic substituted guanidines
CA2149285A1 (en) Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
US7041702B1 (en) Pharmaceutically active compounds and methods of use
JPH069545A (ja) ｏ−置換ベンゾイルグアニジン、その製造方法、医薬または診断剤としてのその使用およびそれを含有する医薬
CZ412898A3 (cs) Substituované cyklopentanové sloučeniny, použitelné jako inhibitory neuraminidázy
EP1032556B1 (en) Pharmaceutically active compounds and methods of use
ES2090024T3 (es) Compuestos de cefemo y procedimientos para su preparacion.
US4840967A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
GB2030985A (en) Substituted furans
US6518458B1 (en) (Aminoiminomethyl) amino) alkane-carboxamides and their applications in therapy
US5658952A (en) 1-[4-(4'-sulfanilyl)phenyl]urea and derivatives for the treatment of Leishmaniasis
US4514390A (en) Melaminylthioarsenites
FI78078B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara p-oxo-oxazolindinylbensensulfonamider.
US6683200B2 (en) N-substituted-N′-substituted urea derivatives and pharmaceutical compositions containing the derivatives
AU2003203801B8 (en) Pharmaceutically active compounds and methods of use
EP0903341A1 (en) "Novel ortho-mercaptoaniline compounds"
NEELAKANTAN Biguanide Derivatives of γ-Pyridones
IL30441A (en) 2-amino-3-amidino-quinoxaline di-n-oxides,their preparation and chemotherapeutical compositions containing them
IE47545B1 (en) N-cyano-n'-alkynyl-n"-(2-mercaptoethyl)-guanidines
EP1918272A1 (en) Pharmaceutically active compounds and methods of use
JPH0556355B2 (cs)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired